PHI with Hepatic fascioliasis infection
How does this condition affect your private health insurance?
Fascioliasis hepatica is a parasitic disease caused by the liver fluke Fasciola hepatica, primarily affecting herbivores but also humans. Infection occurs by ingesting metacercariae from contaminated aquatic plants. The flukes migrate through the liver parenchyma to the bile ducts. This migration causes an acute phase with fever, abdominal pain, hepatomegaly, and eosinophilia. Chronic infection in the bile ducts can lead to inflammation, fibrosis, cholelithiasis, cholangitis, and obstructive jaundice. Diagnosis involves detecting eggs in stool or bile, or antibodies in serum. Treatment involves anthelmintic drugs.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to several months for the acute phase.
Duration of Illness (Lifetime)
One-time event if treated; chronic infection can persist for years if untreated.
Cost of Treatment (Initial)
Hundreds to low thousands of USD, primarily for medication and diagnostics.
Cost of Treatment (Lifetime)
Low to moderate if successfully treated at first occurrence; higher if complications or re-infection occurs.
Mortality Rate
Low (<1%) with prompt treatment; higher in severe, complicated, or untreated cases, especially with cholangitis.
Risk of Secondary Damages
Moderate to high if untreated, including liver damage, cholangitis, gallstones, and obstructive jaundice. Anemia is also possible.
Probability of Full Recovery
High (>90%) with timely and effective anthelmintic treatment, especially before severe complications develop.
Underlying Disease Risk
Low for specific predisposing underlying diseases; however, malnutrition or other parasitic co-infections may exist in endemic areas.